Stockreport

Pharvaris (PHVS) Is Up 11.3% After Deucrictibant Shows 92% Drop in HAE Attacks and Reports Q3 Loss [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF hereditary angioedema attacks over nearly three years, while also reporting a net loss of €37.14 million for the third quarter of 2025. The clinical results, along wit [Read more]